Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg

NCT01020214 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg
DRUG: Benicar HCT® Tablets 40 mg/25 mg

Sponsor

Mylan Pharmaceuticals Inc